USask researchers funded to tackle MS, osteoporosis, and plant health

Three interdisciplinary, multi-institutional projects led by University of Saskatchewan (USask) researchers have each been awarded $250,000 over two years under a federal funding program that fosters innovative high-risk research with the potential for significant and impactful results.

USask researcher targets aggressive breast cancers with new drugs

More than 5,100 women in Canada—about 75 a day—will die from breast cancers this year, a dismal statistic that University of Saskatchewan (USask) radiopharmacist Dr. Humphrey Fonge (PhD) aims to sharply reduce with potent new drugs that specifically target two aggressive types of cancer.